Target intelligence / Profile preview

Netrin receptor UNC5A (UNC5A)

Target
UNC5A
Molecular classification
Receptor, Dependence receptor (a class of receptors that induce apoptosis in the absence of ligand), Immunoglobulin superfamily
01

Overview

Netrin receptor UNC5A is a transmembrane receptor of the immunoglobulin superfamily that binds netrin-1 and mediates repulsive axon guidance signals during neural development[2][3][4][5]. UNC5A serves crucial roles in directing neural growth cone migration and in promoting neurite outgrowth in response to netrin-1, often working together with other netrin receptors such as DCC. Uniquely, UNC5A functions as a "dependence receptor," inducing apoptosis in the absence of netrin-1 ligand, which is thought to contribute to its role as a candidate tumor suppressor[3][5]. In addition to neural patterning, UNC5A is implicated in regulating cell migration and proliferation across multiple tissues, with aberrations or loss of function associated with impaired cell guidance and certain cancers[1][3][4][5]. If you need more information on specific aspects such as structure, binding sites, or signaling partners, please specify.

Other names
UNC5AKIAA1976UNC5H1Protein unc-5 homolog 1Protein unc-5 homolog Anetrin receptor UNC5Anetrin receptor Unc5h1unc-5 homolog 1unc-5 homolog Aprotein unc-5 homolog 1protein unc-5 homolog Aunc-5 (C. elegans homolog) a
02

Mechanism of action

Modulators of netrin-1 or interference with UNC5A ligand binding would affect axon guidance and apoptosis. Small molecules or antibodies that block/activate netrin-1–UNC5A interaction may modulate cell survival and migration (theoretical and preclinical stage)

03

Biological functions

Axon guidanceSignal transduction in neural developmentApoptosis induction (in absence of ligand)Regulation of cell proliferation, migration, and differentiation
04

Disease associations

Cancer (candidate tumor suppressor, especially for its pro-apoptotic role)Neurodevelopmental disorders
05

Safety considerations

Potential risks would include disruption of neural development or unintended triggering of apoptosis in non-target tissues if therapeutically modulated, though no specific safety profile is established
06

Interacting drugs

None directly approved or widely documented; there is no clinically established drug that targets Netrin receptor UNC5A specifically, although experimental agents might exist
07

Biomarkers

Possible involvement as a tumor suppressor or indicator of netrin pathway dysregulation in cancer, but not established as a clinical biomarker

Beyond the preview

Go deeper on Netrin receptor UNC5A (UNC5A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Netrin receptor UNC5A (UNC5A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call